# Bruker (BRKR) — Earnings

BRKR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/brkr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.49 |
| EPS estimate | $0.38 |
| EPS surprise | +27.34% |
| Revenue surprise | −1.77% |
| Revenue | $838.5M |
| Revenue estimate | $853.6M |
| Reported | Aug 4, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1109354/000119312526335226/brkr-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/1ab9c2c1-c0e9-ff0e-eece-426600dc07e3.html) |

Bruker reported Q2 2026 results on August 4, 2026. Earnings per share were $0.49, ahead of the $0.38 estimate by 27.34%. Revenue was $838.5 million, 1.77% short of the $853.6 million consensus. Compared with Q2 2025, EPS rose about 53% from $0.32 and revenue rose about 5% from $797.4 million.

The longer record shows growing sales but softer earnings. Annual EPS was $2.34 in 2022, $2.58 in 2023 and $2.41 in 2024, then fell about 24% to $1.83 in 2025. The first half of 2026 adds up to $0.80, almost level with $0.79 a year earlier. Revenue rose from $588.4 million in Q2 2022 to $838.5 million, about 43% higher. The fourth quarter is the largest of each year in the table, and Q4 2024 set the highs here at $0.76 per share and $979.6 million in revenue. Over the last 20 quarters, Bruker topped the EPS estimate 16 times. Its largest miss was Q2 2025, at 22.24% below.

Bruker reported Q3 results between November 1 and November 5 in each of the past five years. That points to early November 2026 for the next report, which will show whether the recent year-over-year EPS gains continue.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 4, 2026 | $0.38 | $0.49 | 27.34% | $853.6M | $838.5M |
| Q1 2026 | May 6, 2026 | $0.23 | $0.31 | 35.14% | $795.6M | $823.4M |
| Q4 2025 | Feb 12, 2026 | $0.65 | $0.59 | -9.90% | $963.2M | $977.2M |
| Q3 2025 | Nov 3, 2025 | $0.35 | $0.45 | 27.23% | $849.2M | $860.5M |
| Q2 2025 | Aug 4, 2025 | $0.41 | $0.32 | -22.24% | $810.1M | $797.4M |
| Q1 2025 | May 7, 2025 | $0.44 | $0.47 | 7.87% | $768.5M | $801.4M |
| Q4 2024 | Feb 13, 2025 | $0.74 | $0.76 | 3.13% | $975.2M | $979.6M |
| Q3 2024 | Nov 5, 2024 | $0.60 | $0.60 | -0.20% | $866.5M | $864.4M |
| Q2 2024 | Aug 6, 2024 | $0.51 | $0.52 | 1.31% | $799.5M | $800.7M |
| Q1 2024 | May 2, 2024 | $0.47 | $0.53 | 13.93% | $729.9M | $721.7M |
| Q4 2023 | Feb 13, 2024 | $0.68 | $0.70 | 2.44% | $807.4M | $854.5M |
| Q3 2023 | Nov 2, 2023 | $0.63 | $0.74 | 16.90% | $714.6M | $742.8M |
| Q2 2023 | Aug 3, 2023 | $0.49 | $0.50 | 2.71% | $647.8M | $681.9M |
| Q1 2023 | May 4, 2023 | $0.55 | $0.64 | 16.58% | $639.8M | $685.3M |
| Q4 2022 | Feb 9, 2023 | $0.72 | $0.74 | 2.44% | $680.1M | $708.4M |
| Q3 2022 | Nov 3, 2022 | $0.55 | $0.66 | 19.39% | $610.0M | $638.9M |
| Q2 2022 | Aug 3, 2022 | $0.45 | $0.45 | -0.35% | $588.2M | $588.4M |
| Q1 2022 | May 4, 2022 | $0.42 | $0.49 | 16.64% | $572.6M | $595.0M |
| Q4 2021 | Feb 11, 2022 | $0.59 | $0.59 | 0.84% | $661.9M | $683.5M |
| Q3 2021 | Nov 1, 2021 | $0.44 | $0.63 | 42.37% | $575.2M | $608.9M |

## Frequently Asked Questions

### When did Bruker (BRKR) last report earnings?

Bruker last reported on Aug 4, 2026, covering fiscal Q2 2026.

### Did BRKR beat earnings estimates?

Yes. Bruker reported EPS of $0.49 for Q2 2026 against a $0.38 estimate — a 27.34% beat.

### How much revenue did BRKR report last quarter?

Bruker reported $838.5M in revenue for Q2 2026, against a consensus estimate of $853.6M.

## Similar Stocks

- [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock
- [RVTY](https://www.lighthorse.io/tickers/rvty) — Revvity, Inc. Common Stock
- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [WAT](https://www.lighthorse.io/tickers/wat) — Waters Corporation Common Stock
- [MTD](https://www.lighthorse.io/tickers/mtd) — Mettler-Toledo International, Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).